Published May 7, 2025 | Version v1

Occult Hepatitis B Infection in a Decompensated Cirrhosis Patient

Contributors

Hosting institution:

Description

Chronic hepatitis B infection is a common condition encountered in clinical practice, with nearly 2 billion people worldwide showing evidence of infection. It can lead to a wide range of hepatic manifestations, including acute hepatitis, fulminant hepatitis (though rare), cirrhosis, hepatocellular carcinoma (HCC), and even extra-hepatic manifestations. Occult hepatitis B infection (OHB) is a significant area of concern, as many patients may remain undiagnosed and, consequently, miss out on appropriate management. This case highlights a 45-year-old male patient from Burie, Ethiopia, who presented with signs of decompensated liver disease, yet tested negative for Hepatitis B surface Antigen (HBsAg). Further investigation revealed low-level hepatitis B virus (HBV) viremia, confirming occult HBV infection. This underscores the importance of HBV-deoxyribonucleic acid (DNA) testing in HBsAg-negative patients with unexplained cirrhosis. Broader access to hepatitis testing panels and heightened clinical suspicion are essential to ensure timely diagnosis and treatment of OHB, especially in resource-limited settings.

Files

Files (26.8 kB)

Name Size
md5:2453b2064e1c355f4b52c5912031e29a
26.8 kB Download

Additional details

Related works

Is published in
Journal: 3066-3202 (ISSN)

Dates

Accepted
2025-05-07

References

  • 1. Yuen MF, Lim SG, Plesniak R, et al. Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection. N Engl J Med. 2022;387(21):1957-1968. doi:10.1056/NEJMoa2210027 PubMed | Crossref | Google Scholar
  • 2. Seto WK, Lo YR, Pawlotsky JM, Yuen MF. Chronic hepatitis B virus infection. Lancet. 2018;392(10161):2313-2324. doi:10.1016/S0140-6736(18)31865-8 PubMed | Crossref | Google Scholar
  • 3. Said ZN. An overview of occult hepatitis B virus infection. World J Gastroenterol. 2011;17(15):1927-1938. doi:10.3748/wjg.v17.i15.1927 PubMed | Crossref | Google Scholar
  • 4. Gissa SB, Minaye ME, Yeshitela B, et al. Occult hepatitis B virus infection among patients with chronic liver disease of unidentified cause, Addis Ababa, Ethiopia. Sci Rep. 2022;12:13188. doi:10.1038/s41598-022-17336-3 PubMed | Crossref | Google Scholar
  • 5. Bucio-Ortiz L, Enriquez-Navarro K, Maldonado-Rodríguez A, et al. Occult Hepatitis B Virus Infection in Hepatic Diseases and Its Significance for the WHO's Elimination Plan of Viral Hepatitis. Pathogens. 2024;13(8):662. doi:10.3390/pathogens13080662 PubMed | Crossref | Google Scholar
  • 6. Saitta C, Pollicino T, Raimondo G. Occult Hepatitis B Virus Infection: An Update. Viruses. 2022;14(7):1504. doi:10.3390/v14071504 PubMed | Crossref | Google Scholar
  • 7. Zobeiri M. Occult hepatitis B: clinical viewpoint and management. Hepat Res Treat. 2013;2013:259148. doi:10.1155/2013/259148 PubMed | Crossref | Google Scholar
  • 8. Yuen MF. Clinical implication of occult hepatitis B infection. Ann Blood. 2017;2(4):1-10. doi:10.21037/aob.2017.04.01 Crossref | Google Scholar
  • 9. Lalana Garcés M, Pastor OO, Solé Enrech G, et al. Revisión de la infección oculta por el virus de la hepatitis B. Adv Lab Med. 2022;3(4):331-341. doi:10.1515/almed-2021-0084 Crossref | Google Scholar
  • 10. Shi Y, Wu YH, Wu W, Zhang WJ, Yang J, Chen Z. Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis. Liver Int. 2012;32(2):231-240. doi:10.1111/j.1478-3231.2011.02481.x PubMed | Crossref | Google Scholar